All In MedTech

Device Trial Radar · NCT06812572

A Prospective Clinical Study to Evaluate the Repeatability of the Visibly Vision Test

Last checked: Nov 20, 2026Latest source record: Feb 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

25

Actual

Start

Mar 4, 2019

Primary completion

Mar 25, 2019

Study completion Mar 25, 2019

Sponsor

Lead sponsor
VisiblyNot on our public-company list
Sponsor type
Industry
Collaborators
ORA, Inc.
First posted
Feb 6, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a prospective, multi-center, single-arm, non-randomized, non-blinded, observational study to evaluate the test-retest reliability of the Visibly Vision Test. Additionally, observational data will be collected to understand whether the subject performs the set-up process correctly and subject comprehension of the patient labeling will also be evaluated.

Conditions

  • Myopia
  • Astigmatism

Interventions

  • Visibly Vision TestDevice

    The Visibly Vision Test is used as a digital self-administered device to measure visual acuity and to subjectively measure refractive value for a patient's eye to determine the optical prescription for the conditions of myopia and astigmatism

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Test-retest variability (repeatability) of the Visibly Vision Test in the measurement of refractive error as assessed by the repeatability standard deviation using the Visibly software numerical outputs of estimated refractive error/correction.Time frame: Retest conducted between four and 72 hours after initial test.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • TRA

    Harlingen, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.